Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

被引：0
|
作者：
Clifford J Bailey
Jorge L Gross
Delphine Hennicken
Nayyar Iqbal
Traci A Mansfield
James F List
机构：
[1] Aston University,Life and Health Sciences
[2] Universidade Federal do Rio Grande do Sul,Endocrine Division
[3] Bristol-Myers Squibb,Global Biometric Services
[4] Parc de l'Alliance,Global Clinical Research
[5] Bristol-Myers Squibb,undefined
来源：
BMC Medicine | / 11卷
关键词：
Dapagliflozin; metformin; SGLT2; sodium-glucose cotransporter 2; glycemic control; type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial
    Douek, IF
    Allen, SE
    Ewings, P
    Gale, EAM
    Bingley, PJ
    DIABETIC MEDICINE, 2005, 22 (05) : 634 - 640
  • [42] Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian Emil
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Hansen, Lars
    Iqbal, Nayyar
    DIABETES CARE, 2015, 38 (11) : 2009 - 2017
  • [43] Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
    Han, Kyung Ah
    Kim, Yong Hyun
    Kim, Doo Man
    Lee, Byung Wan
    Chon, Suk
    Sohn, Tae Seo
    Jeong, In Kyung
    Hong, Eun-Gyoung
    Son, Jang Won
    Nah, Jae Jin
    Song, Hwa Rang
    Cho, Seong In
    Cho, Seung-Ah
    Yoon, Kun Ho
    DIABETES & METABOLISM JOURNAL, 2023, 47 (06) : 796 - 807
  • [44] A randomised, double-blind phase 3 trial of dapagliflozin add-on to saxagliptin plus metformin in type 2 diabetes
    Mathieu, C.
    Ranetti, A. E.
    Li, D.
    Ekholm, E.
    Cook, W.
    Hirshberg, B.
    Hansen, L.
    Iqbal, N.
    DIABETOLOGIA, 2015, 58 : S356 - S356
  • [45] A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus
    Shestakova, Marina V.
    Wilding, John P. H.
    Wilpshaar, Wim
    Tretter, Reiner
    Orlova, Valeria L.
    Verbovoy, Andrey F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 146 : 240 - 250
  • [46] A randomised, double-blind trial of saxagliptin add-on to dapagliflozin plus metformin
    Catrinoiu, D.
    Matthaei, S.
    Celinski, A.
    Ekholm, E.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Hansen, L.
    DIABETOLOGIA, 2015, 58 : S386 - S386
  • [47] Fixed-dose Combination of Dapagliflozin and Linagliptin in Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomized Double-blind Multicenter Trial
    Kumthekar, Prashant
    Upadhyay, Mihir R.
    Tamma, Rajasekhara Reddy
    Kranti, Vijay
    Bhattacharya, Raja
    Sharma, Prabhat Kumar
    Barge, Vijaykumar Bhagwan
    Revankar, Santosh
    Ghatge, Shweta
    JOURNAL OF DIABETOLOGY, 2025, 16 (01)
  • [48] Effects of metformin in patients with poorly controlled insulin-treated type 2 diabetes mellitus -: A randomized, double-blind, placebo-controlled trial
    Avilés-Santa, L
    Sinding, J
    Raskin, P
    ANNALS OF INTERNAL MEDICINE, 1999, 131 (03) : 182 - +
  • [49] Efficacy and safety of ipragliflozin as an add-on to pioglitazone in Japanese patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study (the SPOTLIGHT study)
    Kashiwagi A.
    Shiga T.
    Akiyama N.
    Kazuta K.
    Utsuno A.
    Yoshida S.
    Ueyama E.
    Diabetology International, 2015, 6 (2) : 104 - 116
  • [50] Efficacy and safety of polyethylene glycol loxenatide as add-on to metformin in patients with type 2 diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 3b trial
    Gao, Fei
    Lv, Xiaofeng
    Mo, Zhaohui
    Ma, Jianhua
    Zhang, Qiu
    Yang, Gangyi
    Liu, Weijuan
    Li, Quanmin
    Zhou, Jian
    Bao, Yuqian
    Jia, Weiping
    DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2375 - 2383
12345